============================================================
QUALITATIVE ERROR ANALYSIS REPORT
Generated on: 2025-08-21 14:56:37
Model: GPT-4o
Dataset: Oscar
============================================================

1. BASIC PERFORMANCE METRICS:
   Accuracy: 0.913
   Precision: 0.921
   Sensitivity: 0.905
   F1-Score: 0.913
   Total samples: 4104
   TP: 1857, TN: 1892, FP: 160, FN: 195

2. SMILES COMPLEXITY ANALYSIS:
   False Positives: 160 cases
     Avg combined SMILES length: 113.7 ± 108.4
   False Negatives: 195 cases
     Avg combined SMILES length: 104.5 ± 40.2
   True Positives: 1857 cases
     Avg combined SMILES length: 106.3 ± 37.1
   True Negatives: 1892 cases
     Avg combined SMILES length: 111.7 ± 63.2

3. GENE TARGET COMPLEXITY ANALYSIS:
   False Positives: 160 cases
     Avg combined gene targets: 8.2 ± 10.3
   False Negatives: 195 cases
     Avg combined gene targets: 9.7 ± 7.4
   True Positives: 1857 cases
     Avg combined gene targets: 10.9 ± 10.2
   True Negatives: 1892 cases
     Avg combined gene targets: 5.1 ± 8.2

4. ORGANISM PATTERN ANALYSIS:
   Top false positives organism pairs:
     Humans - Humans: 120 cases
     Humans - Escherichia coli (strain K12): 4 cases
     Escherichia coli (strain K12) - Humans: 3 cases
     Humans - Enterobacter cloacae: 2 cases
     Humans - None: 2 cases
   Top false negatives organism pairs:
     Humans - Humans: 111 cases
     Staphylococcus aureus - Humans: 26 cases
     Humans - Staphylococcus aureus: 11 cases
     Escherichia coli - Humans: 9 cases
     Humans - Escherichia coli: 7 cases

5. MOST PROBLEMATIC DRUGS:
   Pseudoephedrine: 1.000 error rate
     (1/1 errors: 0 FP, 1 FN)
   Quinidine: 1.000 error rate
     (1/1 errors: 0 FP, 1 FN)
   LY-294002: 1.000 error rate
     (1/1 errors: 1 FP, 0 FN)
   Ponatinib: 1.000 error rate
     (1/1 errors: 1 FP, 0 FN)
   Methylergometrine: 1.000 error rate
     (1/1 errors: 1 FP, 0 FN)
   Brexucabtagene autoleucel: 1.000 error rate
     (1/1 errors: 1 FP, 0 FN)
   Atorvastatin: 1.000 error rate
     (1/1 errors: 1 FP, 0 FN)
   Piretanide: 1.000 error rate
     (2/2 errors: 2 FP, 0 FN)
   Fluvoxamine: 1.000 error rate
     (1/1 errors: 1 FP, 0 FN)
   Ceforanide: 1.000 error rate
     (1/1 errors: 1 FP, 0 FN)

6. SPECIFIC ERROR EXAMPLES:
   False Positives (predicted interaction, but no real interaction):
     1. LY-294002 + Ponatinib
        Organisms: Humans - Humans
        Gene targets: 2 - 15
     2. Methylergometrine + Clofazimine
        Organisms: Humans - Humans
        Gene targets: 2 - 2
     3. Brexucabtagene autoleucel + Atorvastatin
        Organisms: Humans - Humans
        Gene targets: 1 - 5
     4. Piretanide + Dienestrol
        Organisms: Humans - Humans
        Gene targets: 1 - 2
     5. Fluvoxamine + Anisotropine methylbromide
        Organisms: Humans - Humans
        Gene targets: 2 - 3
   False Negatives (missed real interactions):
     1. Methicillin Acyl-Serine + Propranolol
        Organisms: Staphylococcus aureus - Humans
        Gene targets: 1 - 5
     2. Etonogestrel + Glucosamine
        Organisms: Humans - Humans
        Gene targets: 1 - 2
     3. Tazobactam + Bopindolol
        Organisms: Escherichia coli - Humans
        Gene targets: 2 - 5
     4. Flunisolide + Ademetionine
        Organisms: Humans - Humans
        Gene targets: 1 - 8
     5. Methicillin Acyl-Serine + Norethisterone
        Organisms: Staphylococcus aureus - Humans
        Gene targets: 1 - 3

7. SUMMARY INSIGHTS:
   - Model tends to under-predict interactions (more false negatives than false positives)
   - High precision but lower sensitivity - conservative approach, might miss some interactions

Report generation completed successfully.
============================================================
